Atlas Trials

Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)

Clinical trial NCT01470690 · COMPLETED

Trial details

NCT number
NCT01470690
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HCV InfectionsGastric Acid-related Disorders
Start date
2011-10-01
Primary completion
2011-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.